CRISPR Therapeutics AG
€46.1
EUR
Last updated on --.
24h volume5.49K
24h highest46.2025 EUR
24h lowest45.7728 EUR
24h Price movement+0.00%
CRSP recent prices
24 Hours
+0.00%€0.00
30 days
+2.82%+€1.265
60 days
+20.73%+€7.914
90 days
-10.99%-€5.693
Key data
Previous close46.1000 EUR
Market cap4.03B EUR
Volume5.49K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-5.0725 EUR
Net income (FY)-489.62M EUR
Revenue (FY)3.53M EUR
Last report dateMay 4, 2026
About CRISPR Therapeutics AG
HeadquartersZUG
Employees (FY)393.00
Revenue per employee (FY)8.99K EUR
Net income per employee (FY)-1.25M EUR
Listed onNasdaq
CRSP conversion tables
 |  |
|---|---|
| 0.5 CRSP | 23.05 EUR |
| 1 CRSP | 46.1 EUR |
| 5 CRSP | 230.5 EUR |
| 10 CRSP | 461 EUR |
| |
|---|---|
| 0.5 EUR | 0.010846 CRSP |
| 1 EUR | 0.021692 CRSP |
| 5 EUR | 0.10846 CRSP |
| 10 EUR | 0.21692 CRSP |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CRSP is trading at €46.10, +0.00% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CRSP stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CRSP is currently trading at €46.10, +0.00% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CRSP price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CRSP's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CRSP; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CRSP's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
CRISPR Therapeutics AG's market cap is currently 4.03B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume5.49K
24h highest46.2025 EUR
24h lowest45.7728 EUR
24h Price movement+0.00%
Start trade with CRSP Perpetual
Sign up to trade